Artelo Biosciences Inc. (ARTL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Artelo Biosciences Inc.

    NASDAQ: ARTL · Real-Time Price · USD
    4.69
    -0.13 (-2.70%)
    At close: Oct 03, 2025, 3:59 PM
    4.76
    1.59%
    After-hours: Oct 03, 2025, 07:48 PM EDT

    Artelo Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
    Cash & Equivalents
    		 2.34M 2.81M 6.89M 6.63M
    Short-Term Investments
    		 n/a 7.61M 10.64M 3.44M
    Long-Term Investments
    		 n/a n/a -1.5M n/a
    Other Long-Term Assets
    		 3K 3K 3K 189K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 219K 554K 789K 252K
    Total Current Assets
    		 2.56M 10.98M 18.32M 10.32M
    Property-Plant & Equipment
    		 99K 21K 60K 90K
    Goodwill & Intangibles
    		 2.04M 2.04M 2.04M 2.04M
    Total Long-Term Assets
    		 2.14M 2.06M 2.1M 2.32M
    Total Assets
    		 4.7M 13.04M 20.42M 12.63M
    Account Payables
    		 1.68M 1.24M 905K 493K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 40K 28K
    Other Current Liabilities
    		 -3K n/a 53K 5K
    Total Current Liabilities
    		 1.77M 1.29M 998K 526K
    Long-Term Debt
    		 n/a n/a 23K 67K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 69K n/a 23K 67K
    Total Liabilities
    		 1.84M 1.29M 1.02M 593K
    Total Debt
    		 104K 23K 63K 95K
    Book Value
    		 2.86M 11.75M 19.4M 12.04M
    Book Value Per Share
    		 0.89 3.97 41.11 58.03
    Common Stock
    		 3K 3K 3K 25K
    Retained Earnings
    		 -50.14M -40.31M -31.02M -16.9M
    Comprehensive Income
    		 -202K -203K -254K 18K
    Shareholders Equity
    		 2.86M 11.75M 19.4M 12.04M
    Total Investments
    		 n/a 7.61M 9.15M 3.44M

    Add to Watchlist